Medtronic’s diabetes unit MiniMed valued at $5.3 billion as shares fall in Nasdaq debut
March 6 (Reuters) – Shares of MiniMed, the diabetes business of medical device maker Medtronic, opened 4.8% below their offer price in their Nasdaq debut on Friday, valuing it at $5.3 billion. The Northridge, California-based company’s stock opened …